Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 24 citing Chen: Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic.... (0.09 sec) 

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and …


JB Jonas - Acta Ophthalmologica Scandinavica, 2005 - duanesolution.com
Cited by 89 - Related articles - BL Direct - All 5 versions

Intravitreal triamcinolone compared with macular laser grid photocoagulation for …

- doh.gov.tw [PDF] 
T Avitabile, A Longo, A Reibaldi - American journal of ophthalmology, 2005 - Elsevier
Mean follow-up was 9 ± 2 months (range 6 to 12 months). Baseline VA (logarithm of minimal angle of
resolution [logMAR]) and CMT were, respectively, 0.82 ± 0.19 and 556 ± 139 μm microns for the TA
group, 0.84 ± 0.15 and 601 ± 102 ...
Cited by 72 - Related articles - All 29 versions

Intravitreal triamcinolone acetonide: a change in a paradigm


JB Jonas - Ophthalmic Res, 2006 - content.karger.com
Background: Based on experimental studies and clinical observations by Robert Machemer, Gholam
Peyman and others, the vitreous cavity has increasingly been used as a reservoir of drugs for the
direct treatment of intraocular ...
Cited by 46 - Related articles - BL Direct - All 5 versions

Cataract formation and other complications of intravitreal triamcinolone for macular …


JT Thompson - American journal of ophthalmology, 2006 - Elsevier
The mean visual acuity improved from 20/125 to −1 to 20/100 + 2 by one to two months after
injection (P < .001) and was 20/100 at the final examination (P = .006) at a mean of 1.2 years after
injection. Complications included a ...
Cited by 43 - Related articles - All 21 versions

Intravitreal steroids in the management of macular oedema.


S Sivaprasad, P McCluskey, S Lightman - Acta Ophthalmologica …, 2006 - pt.wkhealth.com
The use of intravitreal corticosteroids in the management of macular oedema has recently gained
widespread acceptance. New long-acting steroid preparations and methods of delivery have facilitated
the use of these new modalities. ...
Cited by 28 - Related articles - BL Direct - All 6 versions

Intravitreal triamcinolone acetonide for diabetic retinopathy


J Jonas - Developments in Ophthalmology, 2007 - content.karger.com
Abstract Intravitreal triamcinolone acetonide (IVTA) has been applied in exponentially increas- ing
frequency for various intraocular neovascular and edematous diseases, including diabetic macular
edema, proliferating diabetic ...
Cited by 22 - Related articles - BL Direct - All 5 versions

Triamcinolone acetonide in ocular therapeutics


CM Jermak, JT Dellacroce, J Heffez, GA Peyman - Survey of Ophthalmology, 2007 - Elsevier
Corticosteroids have been used to treat inflammatory conditions of the eye since the 1950s and have
been injected intraocularly since 1974. 95 The purpose of this article is to outline the current use
and highlight the ever-growing ...
Cited by 9 - Related articles - All 4 versions

Macular degeneration: the latest in current medical management

- duanessolution.com
JI LIM - Retina, 2006 - journals.lww.com
Medical therapy of age-related macular degeneration (ARMD) has entered an explosive research era in
which translational research has resulted in several potential treatments for choroidal
neovascularization (CNV). These ...
Cited by 5 - Related articles - BL Direct - All 3 versions

A Moephologic Study of Retinal Toxicity Induced By Triamcinolone Acetonide …

- duanessolution.com [PDF] 
Q Li, J Wang, L Yang, B Mo, H Zeng, N Wang, W Liu - Retina, 2008 - journals.lww.com
From *Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; and
†Peking University Eye Center, Peking University Third Hospital, Beijing, China. Supported in part
by a grant from the National ...
Cited by 4 - Related articles - BL Direct - All 5 versions

[PDF] Klasik Tedaviye Dirençli Diffüz Diabetik Maküla Ödeminde İntravitreal Triamsinolon …


Y YILDIRIM, A AYATA, Ü Melih, M … - Journal of Retina- …, 2005 - retinavitreus.dergisi.org
Amaç: Klasik tedavilere dirençli diffüz diabetik maküla ödemli (DDMÖ) hastalarda intravitreal
triamsinolon asetonid (İVTA) enjeksiyonunun etkinliğini araştırmak. Gereç ve Yöntem: Klasik
tedaviye dirençli DDMÖ 73 ...
Cited by 1 - Related articles - View as HTML - All 7 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google